Published in J Biol Chem on July 17, 2009
Classification of intrinsically disordered regions and proteins. Chem Rev (2014) 2.48
Expanding the proteome: disordered and alternatively folded proteins. Q Rev Biophys (2011) 1.60
Ubiquitin-independent degradation of antiapoptotic MCL-1. Mol Cell Biol (2010) 1.54
The nanny model for IDPs. Nat Chem Biol (2009) 1.18
Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs). Chem Rev (2014) 1.10
The protein level of PGC-1α, a key metabolic regulator, is controlled by NADH-NQO1. Mol Cell Biol (2013) 0.92
E3 ligase STUB1/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients. J Biol Chem (2011) 0.91
STK38 is a critical upstream regulator of MYC's oncogenic activity in human B-cell lymphoma. Oncogene (2012) 0.89
MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response. Oncogene (2015) 0.89
Compromising the 19S proteasome complex protects cells from reduced flux through the proteasome. Elife (2015) 0.86
Cooperation between an intrinsically disordered region and a helical segment is required for ubiquitin-independent degradation by the proteasome. J Biol Chem (2011) 0.85
Splicing up mdm2 for cancer proteome diversity. Genes Cancer (2012) 0.85
Assembly of the SLIP1-SLBP complex on histone mRNA requires heterodimerization and sequential binding of SLBP followed by SLIP1. Biochemistry (2013) 0.85
Context-dependent resistance to proteolysis of intrinsically disordered proteins. Protein Sci (2011) 0.84
Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulators. Front Mol Biosci (2014) 0.82
Glatiramer acetate and nanny proteins restrict access of the multiple sclerosis autoantigen myelin basic protein to the 26S proteasome. Biomed Res Int (2014) 0.80
NADH binds and stabilizes the 26S proteasomes independent of ATP. J Biol Chem (2014) 0.79
A mammalian nervous-system-specific plasma membrane proteasome complex that modulates neuronal function. Nat Struct Mol Biol (2017) 0.78
Control of Pim2 kinase stability and expression in transformed human haematopoietic cells. Biosci Rep (2015) 0.75
Post-translational regulation of p53 function through 20S proteasome-mediated cleavage. Cell Death Differ (2017) 0.75
Surfing the p53 network. Nature (2000) 35.36
Mdm2 promotes the rapid degradation of p53. Nature (1997) 21.26
Regulation of p53 stability by Mdm2. Nature (1997) 18.20
Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol (2005) 17.63
Adapting proteostasis for disease intervention. Science (2008) 13.22
Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science (1996) 9.48
Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet (2004) 8.30
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature (2000) 7.10
The p53 pathway. J Pathol (1999) 6.79
Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol (2003) 5.46
Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J (2005) 5.36
Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem (2009) 5.23
The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature (2004) 5.05
Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell (2003) 4.96
The regulatory particle of the Saccharomyces cerevisiae proteasome. Mol Cell Biol (1998) 4.63
Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell (1993) 4.62
Oscillations and variability in the p53 system. Mol Syst Biol (2006) 4.59
DisProt: the Database of Disordered Proteins. Nucleic Acids Res (2006) 4.46
MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J (1996) 4.13
An unstructured initiation site is required for efficient proteasome-mediated degradation. Nat Struct Mol Biol (2004) 4.11
Tight regulation of unstructured proteins: from transcript synthesis to protein degradation. Science (2008) 3.48
Intrinsic protein disorder in complete genomes. Genome Inform Ser Workshop Genome Inform (2000) 3.47
Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell (2000) 3.42
Structural biology of the tumor suppressor p53. Annu Rev Biochem (2008) 3.36
Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol Cell Biol (1994) 3.05
Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein. J Biol Chem (1999) 2.92
Endoproteolytic activity of the proteasome. Science (2002) 2.56
mdmx is a negative regulator of p53 activity in vivo. Cancer Res (2002) 2.40
Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell (2007) 2.38
Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell (2008) 2.38
Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms. EMBO Rep (2001) 2.27
A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J (2001) 2.22
A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev (2005) 2.21
MDMX overexpression prevents p53 activation by the MDM2 inhibitor Nutlin. J Biol Chem (2006) 2.20
Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell (1995) 2.13
Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo. EMBO J (1996) 1.97
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci U S A (2002) 1.91
alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett (2001) 1.87
Hdmx stabilizes Mdm2 and p53. J Biol Chem (2000) 1.81
NF-kappaB dictates the degradation pathway of IkappaBalpha. EMBO J (2008) 1.81
MDMX regulation of p53 response to ribosomal stress. EMBO J (2006) 1.77
p53 contains large unstructured regions in its native state. J Mol Biol (2002) 1.75
Ubiquitin-independent degradation of proteins by the proteasome. Biochim Biophys Acta (2008) 1.69
20S proteasomes and protein degradation "by default". Bioessays (2006) 1.63
Characterization of rapidly degraded polypeptides in mammalian cells reveals a novel layer of nascent protein quality control. J Biol Chem (2005) 1.62
p53 Stabilization and accumulation induced by human vaccinia-related kinase 1. Mol Cell Biol (2004) 1.56
Molecular basis for the inhibition of p53 by Mdmx. Cell Cycle (2007) 1.55
UV as an amplifier rather than inducer of NF-kappaB activity. Mol Cell (2008) 1.52
Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination. J Mol Biol (2009) 1.43
Some p53-binding proteins that can function as arbiters of life and death. Cell Death Differ (2006) 1.25
The triage of damaged proteins: degradation by the ubiquitin-proteasome pathway or repair by molecular chaperones. FASEB J (2006) 1.23
Kinetics of degradation of "short-" and "long-lived" proteins in cultured mammalian cells. Cell Biol Int Rep (1980) 1.20
Operational definition of intrinsically unstructured protein sequences based on susceptibility to the 20S proteasome. Proteins (2008) 1.20
NMR chemical shift and relaxation measurements provide evidence for the coupled folding and binding of the p53 transactivation domain. Nucleic Acids Res (2005) 1.19
Mechanism of direct degradation of IkappaBalpha by 20S proteasome. FEBS Lett (2005) 1.14
Intrinsically disordered proteins display no preference for chaperone binding in vivo. PLoS Comput Biol (2008) 1.13
Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc Natl Acad Sci U S A (2005) 1.13
Proteasomes begin ornithine decarboxylase digestion at the C terminus. J Biol Chem (2004) 1.11
BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein. J Biol Chem (2007) 1.10
Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6. Oncogene (2007) 1.08
The N terminus of p53 regulates its dissociation from DNA. J Biol Chem (2000) 1.02
Functional dissection of p53 tumor suppressor protein. Methods Enzymol (1997) 0.97
The carboxy-terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome. Oncogene (1997) 0.96
Blinded by the Light: The Growing Complexity of p53. Cell (2009) 17.75
Regulation of p53 activity through lysine methylation. Nature (2004) 5.78
Mutant p53: one name, many proteins. Genes Dev (2012) 4.33
Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci U S A (2010) 4.18
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell (2012) 4.09
hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes. Cell (2007) 3.56
Transcriptional regulation by p53. Cold Spring Harb Perspect Biol (2010) 3.16
TAp63 prevents premature aging by promoting adult stem cell maintenance. Cell Stem Cell (2009) 3.15
Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell (2008) 2.38
P53 and prognosis: new insights and further complexity. Cell (2005) 2.28
The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity. EMBO J (2006) 2.21
A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev (2005) 2.21
p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes Dev (2004) 2.07
p53 linear diffusion along DNA requires its C terminus. Mol Cell (2004) 2.03
Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol Cell (2009) 2.00
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci U S A (2002) 1.91
The Chk2 protein kinase. DNA Repair (Amst) (2004) 1.85
Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2. J Immunol (2005) 1.84
NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci U S A (2002) 1.80
Unleashing the power of p53: lessons from mice and men. Genes Dev (2006) 1.76
20S proteasomes and protein degradation "by default". Bioessays (2006) 1.63
APC/C(Cdc20) targets E2F1 for degradation in prometaphase. Cell Cycle (2010) 1.62
Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology (2003) 1.59
Cyclin G recruits PP2A to dephosphorylate Mdm2. Mol Cell (2002) 1.57
Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry. Genes Dev (2013) 1.57
p53-Dependent induction of PVT1 and miR-1204. J Biol Chem (2011) 1.56
DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation. Mol Cell Biol (2005) 1.56
Mdm2 and PCAF increase Chk2 ubiquitination and degradation independently of their intrinsic E3 ligase activities. Cell Cycle (2009) 1.55
Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. Nat Med (2011) 1.52
Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein. Mol Cell Biol (2002) 1.43
A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint. Genes Dev (2009) 1.42
A role for caspase 2 and PIDD in the process of p53-mediated apoptosis. Proc Natl Acad Sci U S A (2008) 1.40
Nucleotide binding by the Mdm2 RING domain facilitates Arf-independent Mdm2 nucleolar localization. Mol Cell (2003) 1.39
Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression. Am J Pathol (2011) 1.39
20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1. Mol Cell (2005) 1.37
p73alpha regulation by Chk1 in response to DNA damage. Mol Cell Biol (2003) 1.36
The C terminus of p53 binds the N-terminal domain of MDM2. Nat Struct Mol Biol (2010) 1.35
p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer. Clin Cancer Res (2003) 1.35
The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells. Oncogene (2002) 1.35
The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol. Biochemistry (2006) 1.30
Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Proc Natl Acad Sci U S A (2012) 1.30
Questioning the role of checkpoint kinase 2 in the p53 DNA damage response. J Biol Chem (2003) 1.29
Excess HDM2 impacts cell cycle and apoptosis and has a selective effect on p53-dependent transcription. J Biol Chem (2006) 1.28
Mutational analysis of the p53 core domain L1 loop. J Biol Chem (2006) 1.25
p21 differentially regulates DNA replication and DNA-repair-associated processes after UV irradiation. J Cell Sci (2008) 1.24
Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network. PLoS One (2013) 1.22
p53-Dependent p21 mRNA elongation is impaired when DNA replication is stalled. Mol Cell Biol (2006) 1.20
The S phase checkpoint: when the crowd meets at the fork. Semin Cell Dev Biol (2005) 1.20
Operational definition of intrinsically unstructured protein sequences based on susceptibility to the 20S proteasome. Proteins (2008) 1.20
MOZ increases p53 acetylation and premature senescence through its complex formation with PML. Proc Natl Acad Sci U S A (2013) 1.19
Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genes. Mol Cell (2012) 1.19
Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription. J Biol Chem (2002) 1.19
The nanny model for IDPs. Nat Chem Biol (2009) 1.18
The roles of human sucrose nonfermenting protein 2 homologue in the tumor-promoting functions of Rsf-1. Cancer Res (2008) 1.16
PGC-1alpha controls hepatitis B virus through nutritional signals. Proc Natl Acad Sci U S A (2006) 1.16
p53 proteasomal degradation: poly-ubiquitination is not the whole story. Cell Cycle (2005) 1.14
HBXAP, a novel PHD-finger protein, possesses transcription repression activity. Genomics (2002) 1.13
Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc Natl Acad Sci U S A (2005) 1.13
p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation. Proc Natl Acad Sci U S A (2011) 1.10
Caspase 2 is both required for p53-mediated apoptosis and downregulated by p53 in a p21-dependent manner. Cell Cycle (2008) 1.09
Mutant p53 gain of function: the NF-Y connection. Cancer Cell (2006) 1.08
P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1. Proc Natl Acad Sci U S A (2003) 1.06
Cyclin-dependent kinases phosphorylate p73 at threonine 86 in a cell cycle-dependent manner and negatively regulate p73. J Biol Chem (2003) 1.05
P53 and aging: A fresh look at an old paradigm. Aging (Albany NY) (2010) 1.05
p53 in the cytoplasm: a question of overkill? Cell (2004) 1.05
Checkpoint kinase 2 (Chk2) monomers or dimers phosphorylate Cdc25C after DNA damage regardless of threonine 68 phosphorylation. J Biol Chem (2002) 1.04
BIM(EL), an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation. J Cell Sci (2011) 1.04
A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1. Mol Cell (2012) 1.03
c-Abl tyrosine kinase selectively regulates p73 nuclear matrix association. J Biol Chem (2003) 1.02
Inhibition of TFII-I-dependent cell cycle regulation by p53. Mol Cell Biol (2005) 1.00
p53 and Metabolism: The GAMT Connection. Mol Cell (2009) 0.98
p53 and p73 display common and distinct requirements for sequence specific binding to DNA. Nucleic Acids Res (2006) 0.98
DECOD: fast and accurate discriminative DNA motif finding. Bioinformatics (2011) 0.98
Clathrin-mediated endocytosis and lysosomal cleavage of hepatitis B virus capsid-like core particles. J Biol Chem (2006) 0.97
Decreased p21 levels are required for efficient restart of DNA synthesis after S phase block. J Biol Chem (2003) 0.96
p53 is localized to a sub-nucleolar compartment after proteasomal inhibition in an energy-dependent manner. J Cell Sci (2008) 0.95
Enhancer I predominance in hepatitis B virus gene expression. Mol Cell Biol (2004) 0.95
Discovery of Mdm2-MdmX E3 ligase inhibitors using a cell-based ubiquitination assay. Cancer Discov (2011) 0.94
Deconstruction of p53 functions and regulation. Oncogene (2002) 0.94
Autorepression of rfx1 gene expression: functional conservation from yeast to humans in response to DNA replication arrest. Mol Cell Biol (2005) 0.92
Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha. FEBS Lett (2010) 0.92
The protein level of PGC-1α, a key metabolic regulator, is controlled by NADH-NQO1. Mol Cell Biol (2013) 0.92
E3 ligase STUB1/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients. J Biol Chem (2011) 0.91
Stxbp4 regulates DeltaNp63 stability by suppression of RACK1-dependent degradation. Mol Cell Biol (2009) 0.90
RNA interference for antiviral therapy. J Gene Med (2006) 0.90
A regulatory circuit controlling Itch-mediated p73 degradation by Runx. J Biol Chem (2008) 0.90
MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress. Mol Cell Biol (2012) 0.89
The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon. Med Hypotheses (2008) 0.88
UV-triggered p21 degradation facilitates damaged-DNA replication and preserves genomic stability. Nucleic Acids Res (2013) 0.88
Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression. Liver Int (2011) 0.88